Industry: Other Health Care (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-10-09 | New | $14,479,902 | $14,479,902 | Equity Only | 06b | SEC link |
2025-01-08 | Amended | $9,530,050 | $2,029,998 | Equity Only | 06b | SEC link |
2024-09-18 | New | $7,500,052 | $7,500,052 | Equity Only | 06b | SEC link |
2023-06-13 | New | $1,999,991 | $1,999,991 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Garen Bohlin | Director |
Walid Fakhry | Director |
John V Frangioni M.D., Ph.D. | Director, Executive |
John V. Frangioni, M.D., Ph.D. | Director, Executive |
Marc Garnick | Director |
Henry Kay | Director |